Metastatic Castration-resistant Prostrate Cancer
1 clinical trials · Condition
◉ Watch Metastatic Castration-resistant Prostrate Cancer
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies (NCT00730639) | Bristol-Myers Squibb | 2008-10-30 |
Track Metastatic Castration-resistant Prostrate Cancer automatically
Every clearance here is in the API, with alerts when new ones post.